HomeTNGX • NASDAQ
add
Tango Therapeutics Inc
Previous close
$10.76
Day range
$10.58 - $10.97
Year range
$1.04 - $11.19
Market cap
1.47B USD
Avg Volume
4.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 53.81M | 363.61% |
Operating expense | 8.92M | -20.48% |
Net income | 15.88M | 154.46% |
Net profit margin | 29.52 | 111.75% |
Earnings per share | 0.13 | 148.15% |
EBITDA | 14.63M | 145.35% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.81M | -47.90% |
Total assets | 210.14M | -40.37% |
Total liabilities | 50.10M | -59.35% |
Total equity | 160.03M | — |
Shares outstanding | 134.59M | — |
Price to book | 7.52 | — |
Return on assets | 15.70% | — |
Return on capital | 19.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 15.88M | 154.46% |
Cash from operations | -30.95M | 7.30% |
Cash from investing | 47.48M | 45.77% |
Cash from financing | 2.54M | 5.79% |
Net change in cash | 19.07M | 1,105.18% |
Free cash flow | -7.98M | 61.80% |
About
Founded
2017
Headquarters
Website
Employees
155
